醫藥：專業
所有阿根廷公司從事某一行業的公司：醫藥：專業
下面的清單包含在同一產業醫藥：專業下運作的所有阿根廷公司。該清單有助於追蹤他們的績效、損益表等。按任何必要的指標排序，它可以顯示行業中最昂貴的股票，例如：ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25或具有最佳價格動態的股票，例如：NOVARTIS AG CEDEAR EAC 4 REP 1(USD)，從而有助於設計任何焦點的策略。
商品代碼 | 市值 | 價格 | 漲跌 % | 成交量 | 相對成交量 | P/E | 攤薄每股收益 TTM | 每股收益緩慢成長 TTM年增率 | 股息殖利率 % TTM | 部門 | 分析師評級 |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 937.8 T ARS | 19,975.000 ARS | +1.14% | 7.03 K | 1.05 | 105.22 | 189.84 ARS | +513.89% | 0.31% | 健康科技 | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 937.8 T ARS | 16.150 USD | +3.86% | 232 | 0.44 | 87.70 | 189.84 ARS | +381.39% | 0.31% | 健康科技 | — |
 DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)DR | 428.45 T ARS | 1,300.000 ARS | 0.00% | 3 | 0.08 | — | — | — | — | 健康科技 | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 428.45 T ARS | 13,350.000 ARS | +0.95% | 8.41 K | 0.21 | 37.88 | 352.44 ARS | +193.52% | 1.80% | 健康科技 | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 428.45 T ARS | 10.850 USD | 0.00% | 821 | 0.81 | 31.74 | 352.44 ARS | +130.17% | 1.80% | 健康科技 | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 397.17 T ARS | 25,275.000 ARS | +1.30% | 1.24 K | 1.18 | 11.90 | 2,124.76 ARS | +164.67% | 1.55% | 健康科技 | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 397.17 T ARS | 19.600 USD | −3.92% | 16 | 0.28 | 9.51 | 2,124.76 ARS | +107.54% | 1.55% | 健康科技 | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 250.32 T ARS | 22,375.000 ARS | +1.94% | 1.95 K | 0.23 | 18.33 | 1,220.67 ARS | +16,053.66% | 1.67% | 健康科技 | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 250.32 T ARS | 18.700 USD | +3.89% | 20 | 0.13 | 15.79 | 1,220.67 ARS | +12,566.98% | 1.67% | 健康科技 | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 249.37 T ARS | 46,250.000 ARS | +0.60% | 1.04 K | 2.09 | 56.69 | 815.85 ARS | +292.28% | 1.65% | 健康科技 | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 249.37 T ARS | 38.000 USD | 0.00% | 54 | 0.15 | 48.02 | 815.85 ARS | +207.61% | 1.65% | 健康科技 | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 232.35 T ARS | 33,100.000 ARS | −0.23% | 54 | 0.09 | 5.63 | 5,874.32 ARS | −4.22% | 3.34% | 健康科技 | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 232.35 T ARS | 27.200 USD | +4.82% | 1 | 0.32 | 4.77 | 5,874.32 ARS | −24.89% | 3.34% | 健康科技 | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 158.26 T ARS | 7,990.000 ARS | −0.13% | 16.33 K | 0.63 | 25.16 | 317.52 ARS | — | 3.38% | 健康科技 | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 158.26 T ARS | 6.500 USD | −1.22% | 1.21 K | 0.74 | 21.10 | 317.52 ARS | — | 3.38% | 健康科技 | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 129.25 T ARS | 24,150.000 ARS | +1.79% | 434 | 0.41 | — | −1,193.64 ARS | −422.98% | 2.37% | 健康科技 | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USD DR | 129.25 T ARS | 19.300 USD | 0.00% | 1 | 0.10 | — | −1,193.64 ARS | −353.26% | 2.37% | 健康科技 | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 81.51 T ARS | 11,450.000 ARS | +1.33% | 169 | 0.21 | 32.83 | 348.78 ARS | +79.50% | 3.03% | 健康科技 | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 81.51 T ARS | 9.570 USD | +3.57% | 26 | 0.60 | 28.29 | 348.78 ARS | +40.76% | 3.03% | 健康科技 | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 22.07 T ARS | 13,125.000 ARS | 0.00% | 473 | 0.25 | 16.86 | 778.26 ARS | +389.90% | 0.00% | 健康科技 | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 22.07 T ARS | 11.500 USD | +4.07% | 20 | 0.95 | 15.23 | 778.26 ARS | +284.16% | 0.00% | 健康科技 | — |
 RICHLABORATORIOS RICHMOND SACIF | 135.26 B ARS | 1,675.000 ARS | +2.45% | 39.48 K | 2.22 | 17.40 | 96.29 ARS | — | 0.00% | 健康科技 | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4.77 B ARS | 112.000 ARS | +1.82% | 200 | 0.18 | 26.24 | 4.27 ARS | +64.50% | 0.00% | 健康科技 | — |